Cargando…
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
The increasing occurrence of multidrug-resistant strains of the gastric carcinogenic bacterium Helicobacter pylori threatens the efficacy of current eradication therapies. In a previous work, we found that several 1,4-dihydropyridine (DHP)-based antihypertensive drugs exhibited strong bactericidal a...
Autores principales: | González, Andrés, Casado, Javier, Gündüz, Miyase Gözde, Santos, Brisa, Velázquez-Campoy, Adrián, Sarasa-Buisan, Cristina, Fillat, María F., Montes, Milagrosa, Piazuelo, Elena, Lanas, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174938/ https://www.ncbi.nlm.nih.gov/pubmed/35694298 http://dx.doi.org/10.3389/fmicb.2022.874709 |
Ejemplares similares
-
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019) -
Direct Enantiomeric Resolution of Seventeen Racemic 1,4-Dihydropyridine-Based Hexahydroquinoline Derivatives by HPLC
por: Sun, Jiayi, et al.
Publicado: (2019) -
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
por: González, Andrés, et al.
Publicado: (2019) -
Synthesis and Biological Evaluation of New Tricyclic Dihydropyridine Based Derivatives on Potassium Channels
por: Gündüz, Miyase Gözde, et al.
Publicado: (2016) -
Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2021)